Peter Gibbs

44.4k total citations · 8 hit papers
516 papers, 16.1k citations indexed

About

Peter Gibbs is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Peter Gibbs has authored 516 papers receiving a total of 16.1k indexed citations (citations by other indexed papers that have themselves been cited), including 310 papers in Oncology, 121 papers in Pulmonary and Respiratory Medicine and 104 papers in Cancer Research. Recurrent topics in Peter Gibbs's work include Colorectal Cancer Treatments and Studies (171 papers), Genetic factors in colorectal cancer (98 papers) and Cancer Genomics and Diagnostics (76 papers). Peter Gibbs is often cited by papers focused on Colorectal Cancer Treatments and Studies (171 papers), Genetic factors in colorectal cancer (98 papers) and Cancer Genomics and Diagnostics (76 papers). Peter Gibbs collaborates with scholars based in Australia, United States and United Kingdom. Peter Gibbs's co-authors include G. W. Bryan, G. R. Burt, P. L. Pascoe, Christopher W. Lawrence, Peter Matthiessen, Mahin D. Maines, Jeanne Tie, Jayesh Desai, L. G. Hummerstone and Oliver M. Sieber and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Peter Gibbs

485 papers receiving 15.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Decline of the Gastropod Nucella Lapillus Around South-West England: Evidence for the Effect of Tributyltin from Antifouling Paints

1986 650 citations Peter Gibbs et al. profile →
Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer

2011 586 citations Scott Kopetz, Peter Gibbs et al. profile →
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF -Mutated Colorectal Cancer

2015 513 citations Scott Kopetz, Jayesh Desai et al. Journal of Clinical Oncology profile →
Critical appraisal of the evidence for tributyltin-mediated endocrine disruption in mollusks

1998 511 citations Peter Matthiessen, Peter Gibbs Environmental Toxicology and Chemistry profile →
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study

2022 501 citations Luis A. Díaz, Kai‐Keen Shiu et al. profile →
Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer

2015 464 citations Michael Christie, Jayesh Desai et al. Annals of Oncology profile →
The use of the dog-whelk, Nucella lapillus, as an indicator of tributyltin (TBT) contamination

1987 457 citations Peter Gibbs et al. profile →
Reproductive Failure in Populations of the Dog-Whelk, Nucella Lapillus, Caused by Imposex Induced by Tributyltin from Antifouling Paints

1986 407 citations Peter Gibbs et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Gibbs Australia	57	6.1k	4.2k	3.3k	3.2k	2.9k	516	16.1k
Meng Li China	68	1.5k 0.3×	6.2k 1.5×	957 0.3×	266 0.1×	3.1k 1.1×	633	18.1k
J. Carl Barrett United States	69	6.8k 1.1×	10.7k 2.5×	700 0.2×	144 0.0×	5.3k 1.8×	313	21.2k
Randy L. Jirtle United States	66	1.7k 0.3×	9.4k 2.2×	1.7k 0.5×	143 0.0×	1.9k 0.7×	210	18.5k
Roy E. Shore United States	66	3.4k 0.6×	2.2k 0.5×	992 0.3×	60 0.0×	2.4k 0.8×	228	15.9k
Robert A. Baan Netherlands	47	2.4k 0.4×	3.2k 0.7×	3.8k 1.2×	43 0.0×	2.4k 0.8×	144	15.6k
Carlos Rubio-Terrés Sweden	52	3.0k 0.5×	2.8k 0.7×	429 0.1×	46 0.0×	761 0.3×	895	15.1k
Keith R. Solomon Canada	79	513 0.1×	2.6k 0.6×	11.6k 3.6×	641 0.2×	2.2k 0.7×	414	23.9k
Béatrice Secretan France	39	4.0k 0.7×	2.4k 0.6×	3.3k 1.0×	25 0.0×	2.0k 0.7×	64	16.7k
Diana Anderson United Kingdom	57	819 0.1×	6.1k 1.4×	4.4k 1.3×	106 0.0×	6.3k 2.1×	401	19.3k
Tomi P. Mäkelä Finland	61	2.5k 0.4×	7.6k 1.8×	2.1k 0.6×	31 0.0×	1.3k 0.4×	190	12.9k

Countries citing papers authored by Peter Gibbs

Since Specialization

Citations

This map shows the geographic impact of Peter Gibbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Gibbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Gibbs more than expected).

Fields of papers citing papers by Peter Gibbs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Gibbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Gibbs. The network helps show where Peter Gibbs may publish in the future.

Co-authorship network of co-authors of Peter Gibbs

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Gibbs. A scholar is included among the top collaborators of Peter Gibbs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Gibbs. Peter Gibbs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thảo, Lê Thị Phương, Tri‐Long Nguyen, Sean Byars, et al.. (2025). Low-Dose Aspirin for Individualized Cancer Prevention in Older Adults. JAMA Oncology. 11(11). 1348–1348.

Mondal, Utpal K., Jamie E. Newman, Colin MacDougall, et al.. (2025). Blueprint to achieve national exclusive breastfeeding targets by 2030 among Aboriginal Australian women. The Lancet Regional Health - Western Pacific. 60. 101616–101616.

Gibbs, Peter, et al.. (2024). Evolution of Liquid Biopsies for Detecting Pancreatic Cancer. Cancers. 16(19). 3335–3335. 3 indexed citations

Rafiq, Meena, Allison Drosdowsky, Benjamin Solomon, et al.. (2024). Trends in primary care blood tests prior to lung and colorectal cancer diagnosis—A retrospective cohort study using linked Australian data. Cancer Medicine. 13(14). e70006–e70006. 2 indexed citations

André, Thierry, Tae Won Kim, Benny Vittrup Jensen, et al.. (2023). LBA32 Pembrolizumab versus chemotherapy in microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (mCRC): 5-year follow-up of the randomized phase III KEYNOTE-177 study. Annals of Oncology. 34. S1271–S1272. 12 indexed citations

Downie, Jonathan M., Moeen Riaz, Jing Xie, et al.. (2022). Incident Cancer Risk and Signatures Among Older MUTYH Carriers: Analysis of Population-Based and Genomic Cohorts. Cancer Prevention Research. 15(8). 509–519.

Bakshi, Andrew, Yin Cao, Suzanne G. Orchard, et al.. (2022). Aspirin and the Risk of Colorectal Cancer According to Genetic Susceptibility among Older Individuals. Cancer Prevention Research. 15(7). 447–454. 3 indexed citations

Degeling, Koen, Nancy N. Baxter, Jon Emery, et al.. (2021). An inverse stage‐shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID‐19 pandemic. Asia-Pacific Journal of Clinical Oncology. 17(4). 359–367. 56 indexed citations

André, Thierry, Kai‐Keen Shiu, Benny Vittrup Jensen, et al.. (2021). O-8 Final overall survival for the phase 3 KN177 study: Pembrolizumab versus chemotherapy in microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer. Annals of Oncology. 32. S220–S221. 1 indexed citations

10.

Kim, Tae Won, Marc Peeters, Anne Thomas, et al.. (2018). Impact of Emergent Circulating Tumor DNA RAS Mutation in Panitumumab-Treated Chemoresistant Metastatic Colorectal Cancer. Clinical Cancer Research. 24(22). 5602–5609. 41 indexed citations

11.

Peeters, Marc, Timothy Price, Michael Boedigheimer, et al.. (2018). Evaluation of Emergent Mutations in Circulating Cell-Free DNA and Clinical Outcomes in Patients with Metastatic Colorectal Cancer Treated with Panitumumab in the ASPECCT Study. Clinical Cancer Research. 25(4). 1216–1225. 32 indexed citations

12.

Barras, David, Edoardo Missiaglia, Pratyaksha Wirapati, et al.. (2016). BRAF V600E Mutant Colorectal Cancer Subtypes Based on Gene Expression. Clinical Cancer Research. 23(1). 104–115. 161 indexed citations

13.

Kopetz, Scott, Jayesh Desai, Emily Chan, et al.. (2015). Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF -Mutated Colorectal Cancer. Journal of Clinical Oncology. 33(34). 4032–4038. 513 indexed citations breakdown →

14.

Dewhurst, Sally M., Nicholas McGranahan, Rebecca A. Burrell, et al.. (2014). Tolerance of Whole-Genome Doubling Propagates Chromosomal Instability and Accelerates Cancer Genome Evolution. Cancer Discovery. 4(2). 175–185. 287 indexed citations

15.

Wang, Jiping, Luis G. Carvajal‐Carmona, J Chu, et al.. (2013). Germline Variants and Advanced Colorectal Adenomas: Adenoma Prevention with Celecoxib Trial Genome-wide Association Study. Clinical Cancer Research. 19(23). 6430–6437. 8 indexed citations

16.

Jorissen, Robert N., Peter Gibbs, Michael Christie, et al.. (2009). Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer. Clinical Cancer Research. 15(24). 7642–7651. 343 indexed citations

17.

Jorissen, Robert N., Lara Lipton, Peter Gibbs, et al.. (2008). DNA Copy-Number Alterations Underlie Gene Expression Differences between Microsatellite Stable and Unstable Colorectal Cancers. Clinical Cancer Research. 14(24). 8061–8069. 75 indexed citations

18.

Matthiessen, Peter & Peter Gibbs. (1998). Critical appraisal of the evidence for tributyltin-mediated endocrine disruption in mollusks. Environmental Toxicology and Chemistry. 17(1). 37–43. 511 indexed citations breakdown →

19.

Matthiessen, Peter & Peter Gibbs. (1998). CRITICAL APPRAISAL OF THE EVIDENCE FOR TRIBUTYLTIN-MEDIATED ENDOCRINE DISRUPTION IN MOLLUSKS. Environmental Toxicology and Chemistry. 17(1). 37–37. 32 indexed citations

20.

Gibbs, Peter. (1987). A new species of Phascolosoma (Sipuncula) associated with a decaying whale's skull trawled at 880 m depth in the South‐west Pacific. New Zealand Journal of Zoology. 14(1). 135–137. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact